Recently, serum CEA levels have been recommended as a marker to evaluate the survival of patients with locoregional gastrin-independent gastric neuroendocrine tumors (19). The gene discussed is CEACAM5; the disease is gastric neuroendocrine tumor, well differentiated, low or intermediate grade.